Generative AI: Strategies for a Competitive Advantage
The advent of generative AI holds the promise of revolutionizing productivity in both human and business terms. However,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin and Huons sign license and supply agreement for commercialisation of Cyclosporine Ophthalmic…
Lupin expands ophthalmic care reach with treatment for dry eye syndrome and corneal ulcers in the Mexican market
Centaur launches chronic heart failure generic drug In the US
Introduces generic Ivabradine hydrochloride, expanding its US market presence
Advances in neurological research highlight breakthrough therapies
In an exclusive interview, Professor Balaram Ghosh, Associate Professor at the Department of Pharmacy, BITS Pilani Hyderabad,…
Zydus announces non-exclusive patent licensing agreement with Takeda for ‘Vault’ (Vonoprazan) in…
Vonoprazan is a novel gastrointestinal drug and is a next generation treatment for gastro duodenal ulcer and GERD
IIL donates anti-rabies vaccine to economically backward provinces of Vietnam
Initiative aims to supports zoonotic disease prevention efforts
Spinal muscular atrophy market across 7MM to grow to $3 billion by 2033, forecasts GlobalData
Key drivers include Myostatin inhibitors and label expansions, despite impending Spinraza patent expirations
AGC Pharma Chemicals partners with AbilityPharma on pancreatic cancer treatment
Strategic partnership aims to advance ABTL0812 API from clinical trials to global patient access
Fischer Medical Ventures secures marketing rights for Nanyang Biologics’ nutraceuticals in India,…
Global Nutraceuticals market size valued at USD 487.4 billion in 2020 is now projected to grow by 8.3%
Glenmark Pharmaceuticals receives ANDA approval for Topiramate Capsules USP, 15 mg and 25 mg
The drug as been determined by the FDA to be bioequivalent and therapeutically equivalent to Topamax Capsules